Publications

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

Download PDF
Resource: Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

.

Related Articles

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

Link
Acute kidney injury results in long-term alterations of kidney lymphatics in mice

Link